Pediatric Infectious Disease

The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.

An estimated 5.8 million children in the United States have had long COVID, which may occur in up to 20% of children infected with SARS-CoV-2, according to the authors of a new state-of-the-art narrative review published in Pediatrics.

Three pediatric hospitals that discontinued contact precautions for MRSA did not see an associated increase in MRSA over the course of the next 4 years, according to researchers published in the Pediatric Infectious Disease Journal.

Healio spoke with Alexandra Brugler Yonts, MD, director of the post COVID program at Children's National Hospital about questions that parents may have about vaccinating their children against COVID-19.

Healio spoke with Alexandra Brugler Yonts, MD, director of the post COVID program at Children's National Hospital about COVID seasonality and booster schedules.

Healio spoke with Alexandra Brugler Yonts, MD, director of the post COVID program at Children's National Hospital about the latest COVID vaccination advancements for children.

Healio spoke with Alexandra Brugler Yonts, MD, director of the post COVID program at Children's National Hospital about booster recommendations for children with long COVID.

Healio spoke with Alexandra Brugler Yonts, MD, director of the post COVID program at Children's National Hospital about the challenges of diagnosing long COVID in children.

Healio spoke with Alexandra Brugler Yonts, MD, director of the post COVID program at Children's National Hospital about how long COVID presents in children.

NEW YORK — In this video, Matthew Might, PhD, discusses his keynote address at the Infectious Diseases in Children Symposium on how artificial intelligence could “shift” practice in pediatric infectious diseases.